Please login to the form below

Ongentys

This page shows the latest Ongentys news and features for those working in and with pharma, biotech and healthcare.

Neurocrine bags FDA approval for first tardive dyskinesia drug

The COMT inhibitor was approved in Europe as Ongentys last June as an adjunct to Parkinson's disease treatment, and Neurocrine is hoping to meet with the FDA to see what

Latest news

EC approves Bial’s Parkinson’s disease therapy

EC approves Bial’ s Parkinson’ s disease therapy. Ongentys will be given a phase roll-out in 2016 and 2017. ... Manufactured by Bial, Ongentys (opicapone) is indicated as adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Deal Watch February 2017

Royalty monetisation. 150. BIAL/ Neurocrine Biosciences. ONGENTYS (opicapone), COMT inhibitor for Parkinson's disease (approved in EU).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager: £40, 000 - £45, 000 benefits

Senior Account Manager: Competitive salary commensurate with experience

Business Unit Head, Medical Communications, London: Excellent package

Editorial Director – Medical Education (MedComms): Neg

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Healthcare PR Director: £100, 000 – £120, 000 benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Home based, Senior Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Home based, Chief Medical Writer, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Home based, Principal Medical Writer, Medical Communications: Excellent package

Client Services Director - Med Comms: Great salary and bebefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Client Services Director – Healthcare Advertising - London: Neg

Delivery Manager/ Head of Delivery – Executive Search: Neg

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Subscribe to our email news alerts

PMHub

Add my company

Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....